Pharmacology - Questions to Ask When Taking a Drug History

Q1. What medicines are you currently taking?

A: Ask the patient to list all medicines they currently use or explain what each medicine is for.

Why is this useful?

It helps identify the patient’s current medications.

Q2. What types of medicines should you specifically ask about?

A: Ask specifically about:

• Oral contraceptives.
• Over-the-counter (OTC) medicines.
• Herbal preparations.
• Medicines prescribed or recommended by alternative practitioners.

Why is this useful?

Patients may not automatically consider these products to be medicines, so asking directly helps create a complete medication list.

Q3. Why should you ask to see the patient’s actual tablets or medicines?

A: Seeing the medicines can help identify them when the patient cannot remember their names.

With experience, some commonly used medicines can be recognized by their appearance. Examples include:

• Sildenafil, which may be recognized as a blue tablet.
• Amoxicillin, which may appear as maroon-and-gold capsules.

Q4. Why should you ask about medicines taken during the last few days or weeks, even if they have been stopped?

A: Recently discontinued medicines may still explain current symptoms because some adverse effects can appear or persist after treatment has stopped.

Examples include:

• Lung disease associated with amiodarone.
• Adrenal insufficiency following withdrawal of glucocorticoids.

Q5. Why should you ask why a medicine was originally prescribed?

A: Knowing the indication can help:

• Identify the underlying diagnosis.
• Determine whether treatment is still necessary.
• Decide whether therapy should be continued, changed, or stopped.

Examples:

• A patient may describe an unknown medicine simply as a “water tablet” or “blood pressure tablet.”
• A beta-blocker for hypertension may require continuing treatment.
• A medicine used for hyperthyroidism may have been intended only for short-term therapy.

Q6. What should you ask about the dosage regimen?

A: Determine:

• The dose taken each time.
• How frequently it is taken.
• The time of day it is taken.

Why is this useful?

This can show whether adverse effects are related to the medicine or its dosing schedule. It can also help determine whether another regimen might be safer or more effective.

Example:

If one dose of furosemide works effectively but another dose taken 6–8 hours later provides little additional benefit, the regimen may need reassessment. If a nighttime diuretic dose causes nocturia, changing the timing may improve tolerability.

Q7. Why should you ask about the route of administration?

A: The route can help identify the medicine and clarify exactly how the patient uses it.

Examples include:

• Sublingual glyceryl trinitrate (GTN).
• Inhaled salbutamol.

Q8. Why is the duration of treatment important?

A: Knowing how long a medicine has been used can help determine whether an adverse reaction is related to it.

Some adverse reactions occur soon after starting treatment, while others develop only after long-term use.

Examples:

• Penicillin allergy may occur relatively soon after administration.
• Adverse effects from corticosteroids or amiodarone may occur during prolonged treatment.

Q9. Why should you ask whether the medicine has produced beneficial effects?

A: The response to treatment helps determine whether therapy should be continued or modified.

• If the medicine is effective → treatment may be continued.
• If it is ineffective → consider changing the regimen, increasing the dose when appropriate, or changing the medicine.

Examples:

• Triptans for migraine: correct timing of administration can affect effectiveness.
• Bronchodilators: poor response may be related to incorrect inhaler technique.

Q10. Why should you ask about unwanted or adverse effects?

A: Adverse effects may help identify drug-related problems and determine whether treatment needs to be modified.

Examples include:

• Cough caused by ACE inhibitors.
• Bruising associated with anticoagulants.

Q11. Why should you ask about other medicines being taken at the same time?

A: Taking several medicines together can result in drug interactions, which may increase toxicity or reduce treatment effectiveness.

Example:

Warfarin is affected by many drug interactions, and some medicines, such as erythromycin, can precipitate clinically important interactions.

Q12. What should you ask about drug allergies?

A: Start by asking:

“Are you allergic to any medicines?”

If necessary, ask specifically about particular medicines, such as:

“Are you allergic to penicillin?”

If the answer is yes, ask:

“What reaction did you experience?”

Q13. Why is it important to ask what happened during a reported drug allergy?

A: This helps distinguish a true drug allergy from an adverse effect or intolerance.

For example, a patient may report being “allergic” to penicillin when the previous reaction was actually diarrhoea, which is generally an adverse effect rather than an allergic reaction.

Q14. What is the purpose of identifying a genuine drug allergy?

A: Recognizing a true allergy allows the responsible medicine, or related medicines when appropriate, to be avoided in the future, reducing the risk of another allergic reaction.

Pharmacology - Drug History

Q1. Why is it important to take a careful drug history?

A: A detailed drug history is important because it helps to:

• Plan appropriate future treatment.
• Identify whether a medicine may be causing or contributing to an illness.
• Recognize possible drug interactions.
• Detect medicines that may hide important clinical signs.
• Understand whether medicines may have affected investigation results.

Q2. How can medicines mask clinical signs?

A: Some medicines can suppress the normal signs and symptoms of disease.

For example:

• Beta-adrenoceptor antagonists (beta-blockers) may prevent the usual adrenergic symptoms of acute hypoglycaemia. They may also prevent the expected tachycardia during haemorrhage.
• Corticosteroids may reduce abdominal pain and rigidity caused by a perforated abdominal organ. They can also suppress fever associated with infection.

Q3. How can medicines affect investigation results?

A: Certain medicines can alter laboratory test results and make interpretation more difficult. For example, amiodarone can affect thyroid function tests.

Aims of Taking a Drug History

Q4. What is the main aim of taking a drug history?

A: The main aim is to identify all medicines that the patient is currently taking or has stopped taking recently.

Q5. What information should be obtained for each medicine?

A: For every medicine, determine:

• The original reason or indication for starting it.
• The formulation of the medicine.
• The dose taken.
• The frequency of administration.
• The route of administration.
• How long the patient has been taking it.
• Any beneficial effects.
• Any adverse effects.
• Any known allergies.

Q6. How should you ask a patient about their regular medications?

A: Ask the patient which medicines they take regularly. It is generally better to use the word “medicines” rather than “drugs,” because some patients may associate the word “drugs” with recreational or dependent drug use.

Whenever possible, ask the patient to show you the medicine packets, bottles, or containers.

Q7. Can GP medication records or repeat prescription lists always be trusted?

A: No. GP printouts and repeat prescription forms may not accurately represent what the patient is actually taking.

Any differences between the medical record and the patient’s actual medication use should therefore be clarified.

Q8. Which medicines are commonly forgotten by patients when giving a drug history?

A: Patients may forget to mention:

• Oral contraceptive pills.
• Eye drops.

These should therefore be asked about specifically.

Recent Medication Changes

Q9. Why is it important to ask about recent medication changes?

A: Changes in medication are a common cause of adverse drug reactions. For every medicine, establish:

• How long the patient has been taking it.
• Whether the dose has recently changed.
• Whether any medicines have recently been stopped.

Q10. Why should you ask about medicines taken only when required?

A: Medicines taken “as required” can provide useful information about disease control.

For example, frequent use of an as-required bronchodilator may indicate worsening or poorly controlled asthma.

Other Medicines and Substances

Q11. What other types of medicines or substances should be included in a drug history?

A: Ask specifically about:

• Over-the-counter medicines.
• Herbal medicines.
• Alternative medicines, such as homoeopathic preparations.
• Recreational or illegal drugs.

Q12. Why is it important to ask about herbal medicines?

A: Some herbal products contain pharmacologically active substances that may cause adverse effects or interact with prescribed medicines.

Whenever possible, examine the packaging to identify the ingredients.

Q13. What should be considered when asking about recreational or illegal drug use?

A: Ask sensitively about recreational or illegal substances. During physical examination, also look for signs that may suggest their use.

Adverse Effects and Allergies

Q14. What should you ask about medication tolerability?

A: Ask whether the patient tolerates their medicines well and whether they have experienced any unwanted or adverse effects.

Serious suspected adverse drug reactions should be reported through the appropriate adverse-reaction reporting system, such as the Yellow Card system where applicable.

Q15. How else may adverse drug effects be identified?

A: Adverse effects may be detected:

• From the patient’s symptoms.
• During physical examination.
• Through laboratory or other investigation results.

For example, diuretics may cause hypokalaemia, which can be detected through serum electrolyte testing.

Q16. What should be clarified when a patient reports a drug allergy?

A: Ask about the exact reaction to determine whether it represents:

• A true allergic reaction, or
• A drug intolerance or expected adverse effect.

Supporting Safe Medication Use

Q17. Why should you ask how patients manage multiple medicines?

A: Patients taking many medicines may need systems to help them use their medicines safely and correctly.

Examples include:

• A dosette or pill-organizer box.
• Medication administration or supervision by carers.

Q18. Why is it useful to examine the patient’s actual medicines?

A: Examining the medicines can help:

• Confirm their identity.
• Check the exact dose and instructions written on the label.
• Identify errors in administration.
• Identify incorrect storage.

For example, inappropriate storage may affect medicines such as glyceryl trinitrate (GTN).

Drug Examination and Investigation

Q19. What signs related to drug administration can be examined?

A: Examination may include looking for:

• Skin puncture marks associated with injected drugs of abuse.
• Insulin injection sites.
• Correct inhaler technique.

Q20. When may plasma drug concentrations be measured?

A: Plasma drug concentrations may be measured when monitoring drug therapy, assessing toxicity, or determining whether the drug concentration is within the desired therapeutic range.

Assessing Beneficial Drug Effects

Q21. How can the beneficial effects of antihypertensive medicines be assessed?

A: Measure the patient’s blood pressure:

• While lying down.
• While standing.
• After exercise when appropriate.

Q22. What investigation may be monitored in a patient receiving treatment for gout?

A: Serum uric acid levels may be monitored to assess the effectiveness of treatment.

Q23. What test may be used to assess anticoagulant treatment?

A: Prothrombin time, often expressed using the INR for appropriate anticoagulants, may be monitored.

Q24. What investigation helps assess treatment for diabetes mellitus?

A: Blood glucose measurements can be used to assess the effectiveness of diabetes treatment.

Q25. What investigation may be used to assess treatment for anaemia?

A: Haemoglobin levels can be checked to determine whether treatment is improving the anaemia.

Q26. What investigations are useful when monitoring thyroid medication?

A: Thyroid function tests are useful when monitoring patients taking:

• Levothyroxine.
• Antithyroid medicines.

Assessing Adverse Drug Effects

Q27. What physical finding may indicate an adverse drug reaction?

A: A skin rash may indicate an adverse or allergic reaction to a medicine.

Q28. What pupil changes may occur with opioid use?

A: Opioids commonly cause pupillary constriction (miosis).

Q29. Why should blood pressure be checked in patients taking antihypertensive medicines?

A: Antihypertensive medicines may lower blood pressure excessively and cause hypotension, including postural hypotension.

Q30. Why are serum electrolytes monitored in patients taking diuretics?

A: Diuretics can alter electrolyte concentrations, including causing abnormalities such as hypokalaemia.

Q31. What signs may occur in tricyclic antidepressant overdose?

A: Possible findings include:

• Tachycardia.
• Dilated pupils.

Ophthalmology – Floppy Eyelid Syndrome

Basics

Description

Floppy eyelid syndrome (FES) is characterized by an abnormally loose, lax, and easily everted upper eyelid, typically associated with chronic papillary conjunctivitis. The upper eyelid may spontaneously evert during sleep, exposing the conjunctiva and ocular surface to repeated mechanical irritation.

The disorder may be unilateral or bilateral and has a particularly strong association with obstructive sleep apnea–hypopnea syndrome (OSAHS).

Epidemiology

Floppy eyelid syndrome occurs more commonly in males and is strongly associated with obesity and a high body mass index. Either one or both eyes may be affected.

The condition is particularly important because a large proportion of affected patients also have obstructive sleep apnea.

Risk Factors

The major risk factor is obstructive sleep apnea. Obesity and recurrent mechanical trauma to the eyelids, particularly from sleeping face-down or on one side and repeatedly rubbing the eyes, also contribute.

Patients often sleep preferentially on the side of the more severely affected eye.

Prevention

Recognition and treatment of associated obstructive sleep apnea are important. Treatment with continuous positive airway pressure (CPAP) may improve both the sleep apnea and manifestations of floppy eyelid syndrome.

Reducing chronic eye rubbing and mechanical trauma to the eyelids may also be beneficial.

Pathophysiology

The upper eyelid becomes abnormally lax because of structural abnormalities involving the tarsal plate and elastic tissue.

Repeated mechanical trauma during sleep and recurrent ischemia-reperfusion injury may increase the activity of matrix metalloproteinases, enzymes that degrade elastin. Progressive loss and alteration of elastic fibers weaken the eyelid and allow it to evert easily.

Once the eyelid begins everting during sleep, the exposed conjunctiva and cornea undergo repeated mechanical irritation, creating a cycle of inflammation, ocular surface exposure, and further eyelid damage.

Etiology

The precise cause is not completely understood. Important contributing mechanisms include elongation and weakening of the tarsal plate, chronic mechanical trauma, repeated eye rubbing, and abnormalities of elastic tissue.

Obstructive sleep apnea is strongly associated with the condition and may contribute through intermittent hypoxia and ischemia-reperfusion injury.

Associated Conditions

The most important association is obstructive sleep apnea–hypopnea syndrome, reported in a very high proportion of patients with classic floppy eyelid syndrome.

Other associations include obesity, keratoconus, chronic ocular surface disease, ptosis, and eyelid malposition.

Keratoconus may be particularly prominent on the side on which the patient habitually sleeps or rubs the eye.

OSA itself has important systemic associations, including cardiovascular disease, stroke, metabolic syndrome, cognitive and emotional disturbances, and excessive daytime sleepiness.

Diagnosis

History

Patients commonly report chronic ocular irritation, foreign-body sensation, redness, tearing, and mucous discharge. Symptoms are often particularly severe upon awakening in the morning.

Some patients are aware that their upper eyelid spontaneously turns outward while sleeping. They may report sleeping predominantly on the affected side of the face.

A history of loud snoring, witnessed apneic episodes, daytime somnolence, obesity, or previously diagnosed sleep apnea should be specifically sought.

Smoking and habitual eye rubbing should also be documented.

Physical Examination

The characteristic finding is an extremely lax upper eyelid that can be everted easily with minimal manipulation.

The upper tarsal plate often feels unusually soft and rubbery, and significant horizontal eyelid laxity may be present. The lower eyelid may also demonstrate increased laxity.

The eyelashes may point downward, producing lash ptosis.

Eversion of the upper eyelid commonly reveals chronic papillary conjunctivitis.

Other findings may include ptosis and lagophthalmos. Incomplete eyelid closure and nocturnal exposure may produce punctate epithelial keratitis, particularly when ocular surface disease is advanced.

Diagnostic Testing

Patients suspected of having associated obstructive sleep apnea should undergo appropriate evaluation, commonly including a sleep study or polysomnography.

This aspect of the evaluation is particularly important because untreated sleep apnea carries significant systemic morbidity.

The ophthalmic examination should carefully assess the cornea for punctate epithelial erosions, abrasions, ulceration, thinning, scarring, or other evidence of exposure-related disease.

Differential Diagnosis

Conditions that may resemble floppy eyelid syndrome include ptosis, chronic blepharoconjunctivitis, ectropion, vernal keratoconjunctivitis, giant papillary conjunctivitis, and superior limbic keratoconjunctivitis.

The combination of marked upper eyelid laxity, easy spontaneous eversion, chronic papillary conjunctivitis, and symptoms that are worse after sleep strongly favors floppy eyelid syndrome.

Treatment

First-Line Treatment

Initial treatment is directed toward protecting and lubricating the ocular surface.

Artificial tears may be used during the day, while more viscous gels or ophthalmic ointments provide longer-lasting protection and are particularly useful before sleep.

At night, the eyelids may be gently taped closed or protected with an eye shield to prevent spontaneous eversion and reduce mechanical trauma to the ocular surface.

Treatment of Obstructive Sleep Apnea

Associated obstructive sleep apnea should be actively treated. CPAP therapy is a central treatment for appropriate patients and may improve the eyelid disorder in addition to reducing the systemic consequences of sleep apnea.

Depending on the severity and cause of OSA, additional management may include behavioral measures, weight management, mandibular advancement devices, or selected surgical procedures.

Additional Medical Treatment

In selected patients with significant inflammatory or meibomian gland-related disease, systemic therapy such as doxycycline may be considered by the treating clinician.

Treatment should also address associated ocular surface inflammation, blepharitis, keratoconus, or exposure keratopathy when present.

Surgical Treatment

Surgery is considered when conservative treatment and management of associated sleep apnea fail to provide adequate control.

When possible, significant obstructive sleep apnea should be addressed before definitive eyelid surgery.

Surgical options primarily aim to restore normal eyelid tension. These include horizontal eyelid shortening or canthal tightening procedures and, in selected cases, full-thickness eyelid resection.

Surgical treatment may simultaneously improve associated ptosis in some patients.

Recurrence can occur, and some patients eventually require additional eyelid procedures.

Follow-Up

Patients with active ocular surface disease require relatively close ophthalmologic follow-up, particularly when there is corneal involvement.

The cornea should be monitored for epithelial breakdown, exposure keratopathy, ulceration, infection, thinning, and scarring.

Long-term follow-up should also assess the effectiveness of sleep apnea treatment and the persistence or recurrence of eyelid laxity.

Patient Education

Patients should understand the particularly important relationship between floppy eyelid syndrome and obstructive sleep apnea.

Symptoms such as loud snoring, witnessed apnea, morning headaches, excessive daytime sleepiness, or unexplained fatigue should prompt appropriate sleep evaluation.

Patients should also be instructed to minimize eye rubbing and nocturnal mechanical trauma and to use prescribed lubrication and nighttime eyelid protection consistently.

Prognosis

The prognosis is generally favorable when both the ocular surface disease and associated sleep apnea are appropriately treated.

Treatment of obstructive sleep apnea with CPAP may improve floppy eyelid syndrome in some patients and, more importantly, reduces the substantial systemic risks associated with untreated sleep apnea.

Persistent severe eyelid laxity may require surgical correction, and recurrence after surgery is possible.

Complications

Chronic exposure and mechanical trauma can lead to corneal abrasion, epithelial breakdown, ulceration, infection, scarring, thinning, and, in severe cases, corneal perforation.

Floppy eyelid syndrome and its strong association with obstructive sleep apnea have also been reported alongside important ophthalmic disorders such as keratoconus, normal-tension glaucoma, nonarteritic ischemic optic neuropathy, and papilledema.

Ophthalmology – Fetal Alcohol Syndrome

Fetal alcohol syndrome (FAS) represents the most severe end of the fetal alcohol spectrum disorders (FASD), a group of developmental abnormalities caused by prenatal alcohol exposure. FAS is characterized by abnormalities in three major domains: growth restriction, characteristic facial features, and central nervous system dysfunction or structural abnormalities.

Typical facial features include short palpebral fissures, a thin upper vermilion border, and a smooth philtrum. Growth restriction is generally defined as height or weight at or below the 10th percentile. Central nervous system abnormalities may include structural brain anomalies, reduced head circumference, developmental impairment, or neurobehavioral dysfunction.

FAS may be diagnosed either with or without confirmed maternal alcohol exposure, although a documented history strengthens the diagnosis. Partial FAS is used when characteristic facial abnormalities are present but only one of the other major diagnostic domains is fulfilled.

Epidemiology and Risk Factors

The estimated prevalence of FAS is approximately 0.5–2 cases per 1,000 live births, although true rates vary between populations and are difficult to determine because prenatal alcohol exposure is frequently underreported.

The major risk factor is maternal alcohol consumption during pregnancy. Heavy daily intake and binge drinking carry particularly high risk, but a completely safe threshold has not been established.

Genetic factors may modify susceptibility. Variants in genes involved in alcohol metabolism, including ADH1B and CYP2E1, have been investigated as possible modifiers of fetal risk. However, prenatal alcohol exposure remains the essential causal factor.

Prevention

FAS is considered preventable by avoiding alcohol during pregnancy. Because alcohol exposure can occur before pregnancy is recognized, avoidance is also important when pregnancy is planned or possible.

Screening for unhealthy alcohol use and appropriate behavioral counseling before and during pregnancy can reduce fetal exposure.

Pathophysiology

Alcohol is a proven teratogen. The precise mechanisms by which it damages the developing fetus are complex and incompletely understood.

Ethanol and its metabolites, including acetaldehyde, can interfere with embryonic development during critical periods of gastrulation and neurulation. Proposed mechanisms include oxidative stress, free-radical formation, interference with cellular signaling, altered gene transcription, impaired neural crest development, and disruption of neuronal proliferation and migration.

Because the eyes and central nervous system develop closely together, prenatal alcohol exposure can affect the eyelids, globe, retina, optic nerve, and visual pathways.

Associated Systemic Features

Children with FAS may have growth restriction, developmental delay, learning disabilities, reduced IQ, behavioral disorders, poor adaptive functioning, impaired social judgment, and communication difficulties.

Attention-deficit/hyperactivity disorder and other psychiatric or behavioral disorders are common. Some affected individuals later develop problems with substance use and mental health.

Congenital heart defects and other systemic malformations may also occur.

Ophthalmic Manifestations

Ocular abnormalities are common in FAS. External features may include short palpebral fissures, ptosis, epicanthal folds, and telecanthus.

The globe may be smaller than normal, producing microphthalmos.

Strabismus, particularly esotropia, is common and can lead to amblyopia if untreated.

Visual acuity may be reduced in one or both eyes. Refractive errors are also common, with myopia frequently reported.

Anterior segment abnormalities and media opacities can occur. Posterior segment findings may include retinal dysplasia and tortuous retinal vessels.

One of the most important abnormalities is optic nerve hypoplasia, which may cause substantial and permanent visual impairment.

Severely affected children may also have cortical visual impairment, reflecting damage to central visual pathways rather than the eyes themselves.

Diagnosis

A careful prenatal history should assess possible maternal alcohol exposure, although clinicians should recognize that alcohol consumption may be underestimated or underreported.

The physical examination should evaluate growth, head circumference, characteristic facial features, neurologic development, and associated congenital abnormalities.

A complete ophthalmic evaluation should assess visual acuity or age-appropriate visual behavior, ocular alignment, eyelid anatomy, cycloplegic refraction, anterior segment structures, retina, and optic nerves.

Because visual problems can interfere further with development and learning, ophthalmologic abnormalities should be identified as early as possible.

Diagnostic Testing

There is currently no single reliable laboratory test that confirms fetal alcohol syndrome.

Several biochemical markers of maternal alcohol exposure have been investigated, including fatty acid ethyl esters in meconium or hair, gamma-glutamyl transferase, carbohydrate-deficient transferrin, and acetaldehyde-associated markers. None is sufficiently sensitive and specific to replace clinical diagnosis.

CT or MRI of the brain may be useful when structural central nervous system abnormalities are suspected.

Electroretinography has shown variable findings and is not a standard diagnostic test for FAS.

Differential Diagnosis

Several genetic and congenital syndromes can resemble the facial or ophthalmic findings of FAS. Important differential diagnoses include velocardiofacial syndrome, Williams syndrome, blepharophimosis syndrome, and Dubowitz syndrome.

Because prenatal alcohol exposure may coexist with an unrelated genetic disorder, atypical features should prompt consideration of clinical genetics or dysmorphology consultation.

Treatment

There is no medication that reverses the congenital ocular abnormalities of FAS. Management is therefore directed toward maximizing visual development and treating specific ocular problems.

Refractive errors should be corrected promptly with appropriate spectacles or other optical correction.

If amblyopia is present, treatment may include patching of the better-seeing eye or other standard amblyopia therapy.

Strabismus surgery may be indicated when significant ocular misalignment persists despite optical and amblyopia treatment.

Ptosis surgery may be considered when eyelid drooping interferes with the visual axis or causes significant functional impairment.

Children with optic nerve hypoplasia, cortical visual impairment, or other permanent visual deficits may benefit from low-vision and developmental services.

Associated systemic and neurodevelopmental disorders require multidisciplinary care.

Follow-up

Children with FAS should have ongoing ophthalmologic follow-up, particularly during the amblyogenic years.

Monitoring should include visual acuity, refractive error, ocular alignment, amblyopia, ptosis, and optic nerve function.

The frequency of follow-up depends on the severity of ocular involvement. Children with significant strabismus, amblyopia, or refractive error require more frequent examinations.

Patient Education

Families should understand that many behavioral, developmental, and learning problems are manifestations of the underlying neurodevelopmental disorder and may require long-term educational, behavioral, and medical support.

Parents should also understand the importance of early treatment of refractive error and strabismus, because preventable amblyopia can compound visual impairment caused by FAS.

When ongoing maternal alcohol misuse is identified, referral for appropriate substance-use treatment and support services is important.

Prognosis

Visual prognosis depends on the specific ocular abnormalities. Children whose reduced vision is primarily caused by refractive error or amblyopia can improve substantially when diagnosed and treated early.

Visual loss from optic nerve hypoplasia, retinal abnormalities, or cortical visual impairment may be permanent.

Early ophthalmologic evaluation in infancy or the preschool years provides the best opportunity to preserve useful vision and prevent avoidable visual disability.

Complications

The major ophthalmic complication is permanent reduction in visual acuity from untreated amblyopia, particularly when associated with strabismus, anisometropia, or significant refractive error.

More severe congenital abnormalities, including optic nerve hypoplasia and cortical visual impairment, can cause substantial lifelong visual disability.

Ophthalmology – Familial Exudative Vitreoretinopathy

Familial exudative vitreoretinopathy (FEVR) is a rare inherited retinal vascular disorder in which abnormal development of the retinal circulation leaves an area of peripheral avascular retina. The resulting peripheral retinal ischemia can stimulate neovascularization, exudation, fibrosis, vitreoretinal traction, retinal folds, macular ectopia, and tractional retinal detachment. Advanced disease may also produce cataract, neovascular glaucoma, and band keratopathy.

FEVR is usually bilateral, but the two eyes can be strikingly asymmetric. Disease severity varies enormously, even among members of the same family and between the two eyes of a single patient. Many affected individuals remain asymptomatic throughout life, whereas others develop severe visual loss or complete blindness in infancy. Importantly, FEVR can progress even after many years of apparent stability.

Epidemiology and Genetics

The true incidence and prevalence are unknown because many affected individuals have mild disease and remain undiagnosed. Molecular and family studies suggest that a very large proportion of affected people may be asymptomatic.

The most common inheritance pattern is autosomal dominant, although autosomal recessive and X-linked forms also occur. Penetrance is high when careful peripheral retinal examination and fluorescein angiography are used, but clinical expression is extremely variable.

Several genes involved in the Norrin–β-catenin signaling pathway have been associated with FEVR. Important genes include FZD4, NDP, LRP5, and TSPAN12. This pathway is essential for normal retinal vascular development.

Mutations in NDP can also cause Norrie disease, an X-linked disorder characterized by severe congenital retinal disease and sometimes hearing loss and developmental abnormalities.

Patients with LRP5-associated FEVR may have reduced bone mass, so systemic skeletal assessment may occasionally be relevant.

Pathophysiology

The primary abnormality in FEVR is incomplete peripheral retinal vascularization. Defective signaling in pathways responsible for retinal vasogenesis leaves an avascular peripheral retina, most commonly temporally.

This avascular retina becomes relatively ischemic and can stimulate production of angiogenic factors. Secondary changes may include abnormal vascular branching, arteriovenous shunts, neovascularization, lipid exudation, and fibrovascular proliferation.

As fibrovascular tissue contracts, it produces vitreoretinal traction, which can drag the macula and optic disc temporally, create retinal folds, and eventually cause tractional retinal detachment. Some eyes may also develop retinal breaks and combined tractional-rhegmatogenous detachment.

Clinical Presentation

A detailed history should include a family history of retinal disease, visual loss, retinal detachment, or childhood blindness. It is also important to ask about prematurity and neonatal oxygen exposure, because retinopathy of prematurity can closely resemble FEVR.

Many affected individuals are asymptomatic and are diagnosed only after examination of family members of a known case.

Infants with severe disease may present with poor fixation and following, pendular nystagmus, strabismus, or leukocoria caused by extensive retinal detachment or heavy lipid exudation.

Older children and adults may present with gradual or sudden visual loss due to retinal detachment, retinal folds, vitreous hemorrhage, or macular ectopia.

Some patients develop apparent exotropia because temporal displacement of the macula produces a large positive angle kappa, creating pseudoexotropia.

Physical Examination

Visual acuity ranges from normal to profound visual loss. A complete dilated retinal examination with careful peripheral evaluation and scleral depression is essential.

The hallmark finding is a peripheral avascular zone, usually most prominent temporally but sometimes extending circumferentially.

At the vascular-avascular junction, retinal vessels may have a brush-like appearance, excessive branching, dilation, tortuosity, or abnormal peripheral looping.

Additional findings can include peripheral neovascularization, vitreous hemorrhage, subretinal lipid exudation, vitreoretinal fibrosis, retinal folds, macular ectopia, temporal dragging of the retina and optic disc, and tractional retinal detachment.

Fluorescein Angiography

Fluorescein angiography, preferably with wide-field peripheral imaging, is one of the most useful diagnostic tests.

Typical angiographic abnormalities include abrupt termination of the peripheral capillary bed, avascular peripheral retina, abnormal peripheral vessel branching, arteriovenous shunts, vascular tortuosity, leakage from abnormal peripheral vessels, and temporal dragging of retinal vessels.

Wide-field angiography is particularly valuable because clinically subtle disease may become obvious only when the far peripheral circulation is examined.

Differential Diagnosis

The condition that most closely resembles FEVR is retinopathy of prematurity (ROP). The distinction depends heavily on history. ROP occurs in premature infants, particularly those with a history of neonatal intensive care and oxygen exposure, whereas FEVR may occur in full-term infants and often has a positive family history.

Other differential diagnoses include persistent fetal vasculature, Norrie disease, X-linked retinoschisis, incontinentia pigmenti, Coats disease, pars planitis, and ocular toxocariasis.

The combination of a peripheral avascular retina, asymmetric bilateral disease, and a positive family history strongly supports FEVR.

Treatment

Treatment is determined by the stage and activity of disease.

Eyes with peripheral avascular retina alone, without neovascularization, exudation, or traction, are usually observed.

When significant peripheral neovascularization or exudation develops, laser photocoagulation to the avascular peripheral retina is commonly used. Cryotherapy can also be considered when laser treatment is technically difficult.

The goal is to reduce ischemic drive and prevent progression to fibrovascular traction and retinal detachment.

Anti-VEGF agents have been used in selected cases with severe exudative or neovascular disease, but their role requires caution because rapid regression of neovascular tissue may potentially increase fibrovascular contraction and traction. They are therefore generally considered adjunctive rather than routine therapy.

Surgical Management

Eyes with retinal detachment require treatment according to the extent and mechanism of traction.

Mild tractional detachment that does not involve the fovea may sometimes be managed with scleral buckling.

More advanced tractional retinal detachment generally requires pars plana vitrectomy, often with membrane dissection and other vitreoretinal techniques. Complex cases may require combined vitrectomy and scleral buckle procedures.

Surgery can be technically difficult because of abnormal peripheral vasculature and extensive vitreoretinal adhesions.

Follow-up

Long-term monitoring is essential because FEVR can remain stable for years and subsequently reactivate or progress.

Patients with only peripheral avascularity and no active complications may sometimes be followed annually.

Patients with neovascularization, exudation, or traction require much closer follow-up, particularly during periods of active treatment.

Children require particularly careful surveillance because progression can occur rapidly and because retinal pathology may interfere with visual development and cause amblyopia or strabismus.

Family Screening and Genetic Counseling

Because FEVR is inherited and may be clinically subtle, first-degree relatives should undergo retinal examination, often including wide-field fluorescein angiography when indicated.

Genetic counseling should be offered according to the identified or suspected mode of inheritance. Molecular testing can be helpful for confirming the diagnosis and screening family members, although a negative genetic test does not exclude FEVR because not all causative genes are known.

Prognosis

The prognosis is highly variable. Patients with mild peripheral vascular abnormalities may maintain normal vision throughout life, whereas those presenting in infancy with extensive retinal detachment generally have a poorer visual prognosis.

Early recognition of neovascularization and exudation before significant retinal traction develops provides the best opportunity to preserve useful vision.

Even apparently stable patients require lifelong follow-up because progression can occur after prolonged periods of inactivity.

Complications

Major complications include peripheral neovascularization, vitreous hemorrhage, lipid exudation, arteriovenous malformations, vitreoretinal fibrosis, falciform retinal folds, macular ectopia, retinal tears, tractional or combined retinal detachment, cataract, neovascular glaucoma, and blindness.

Ophthalmology – Eyelid Neoplasms, Malignant

Malignant eyelid neoplasms can arise from virtually any tissue of the ocular adnexa. Early recognition is critical because these tumors can cause local tissue destruction, orbital invasion, lymphatic or hematogenous spread, visual loss, and potentially death. The major malignant eyelid tumors are basal cell carcinoma (BCC), squamous cell carcinoma (SCC), sebaceous gland carcinoma, and malignant melanoma. Less common malignant lesions include Merkel cell carcinoma, Kaposi sarcoma, cutaneous T-cell lymphoma, and MALT lymphoma.

Approximately 5–10% of all skin cancers involve the eyelid. Basal cell carcinoma is by far the most common malignant eyelid tumor, accounting for approximately 80–90% of cases. Squamous cell carcinoma accounts for roughly 5–10%, sebaceous carcinoma for approximately 1–5%, and malignant melanoma for about 1% or less.

The most important risk factor is chronic ultraviolet exposure. Other risk factors include fair skin, Caucasian ethnicity, advanced age, previous skin cancer, immunosuppression, previous radiation, chronic scars or burns, and arsenic exposure. Preventive measures therefore include limiting excessive sun exposure and using appropriate UV protection, especially from childhood onward.

Pathophysiology

Chronic ultraviolet radiation can cause mutations and defects in DNA repair pathways. When damaged cells escape normal regulatory mechanisms, they may undergo malignant transformation and proliferate uncontrollably.

The biologic behavior varies considerably among tumor types. Some lesions, such as BCC, are usually slow growing and rarely metastasize but can become profoundly locally destructive. Others, particularly sebaceous carcinoma and melanoma, possess substantial metastatic potential.

⸻

Basal Cell Carcinoma

Basal cell carcinoma arises from basal cells of the epidermis. It is the most common malignant eyelid tumor and most frequently involves the lower eyelid, followed by the medial canthus, upper eyelid, and lateral canthus.

BCC generally grows slowly and metastasizes only rarely. However, it can be locally invasive, particularly when located near the medial canthus, where spread into the orbit and adjacent structures may occur before the extent of disease is clinically obvious.

The classic form is a pearly, firm, indurated nodule with surface telangiectatic vessels, sometimes accompanied by central ulceration. Nodulo-ulcerative lesions may produce the characteristic appearance of a central ulcer with raised pearly borders.

The morpheaform or sclerosing subtype is flatter and more infiltrative. It may appear as a firm, pale or yellow-white plaque with indistinct borders and relatively intact overlying epidermis. Because the clinical margins are poorly defined, complete removal can be more difficult.

Superficial multifocal BCC involves a broader area of the epidermis and dermis and may have a more irregular surface.

⸻

Squamous Cell Carcinoma

Squamous cell carcinoma arises from the squamous epithelial layer of the epidermis. Unlike BCC, SCC may develop from premalignant lesions such as actinic keratosis, Bowen disease, or radiation-related skin damage.

The lower eyelid is the most common site, followed by the medial canthus, upper eyelid, and lateral canthus. SCC may present as a painless nodule, plaque, ulcerated lesion, or crusted lesion and can sometimes resemble basal cell carcinoma.

SCC has a greater tendency than BCC to metastasize to regional lymph nodes. Particularly concerning is perineural invasion, because tumor cells can track along nerves into the orbit, intracranial cavity, or surrounding facial structures.

Histologically, invasive SCC demonstrates atypical squamous cells crossing the basement membrane into the dermis, often with keratin pearls and dyskeratotic cells.

⸻

Sebaceous Gland Carcinoma

Sebaceous gland carcinoma most commonly arises from the meibomian glands of the eyelid or the glands of Zeis. It is an especially important tumor because it frequently masquerades as a benign inflammatory disorder.

It may present as a recurrent or persistent chalazion, chronic unilateral blepharitis, or blepharoconjunctivitis. For this reason, it is often called the “great masquerader.”

The upper eyelid is commonly involved because it contains a greater number of meibomian glands.

A key clinical warning sign is loss of eyelashes (madarosis) in the region of the lesion. Sebaceous carcinoma can be multicentric and may spread within the epithelium in a pagetoid pattern, involving areas beyond the clinically visible tumor.

The tumor can spread directly into the orbit, paranasal sinuses, and intracranial structures, and can metastasize through lymphatic pathways to regional lymph nodes and distant organs.

Because recurrence after treatment is possible, long-term surveillance is essential.

⸻

Malignant Melanoma

Malignant melanoma of the eyelid results from malignant proliferation of melanocytes. Although uncommon, melanoma is clinically important because it has significant metastatic potential and is a major cause of death from primary skin tumors.

Major forms include superficial spreading melanoma, nodular melanoma, lentigo maligna melanoma, and acral lentiginous melanoma.

Superficial spreading melanoma may appear as an elevated lesion with irregular pigmentation containing combinations of black, brown, tan, rose, gray, or blue.

Nodular melanoma typically forms a raised spherical lesion with a relatively uniform blue-black appearance.

Lentigo maligna melanoma develops from a longstanding pigmented macule that later develops elevation or nodularity.

Tumor thickness is an important prognostic factor. Breslow thickness, which measures the depth of invasion in millimeters, is more clinically important than the older Clark level classification.

Patients require careful systemic assessment because metastatic melanoma can involve regional lymph nodes and distant organs.

⸻

Associated Genetic and Systemic Conditions

Several inherited syndromes substantially increase the risk of malignant eyelid tumors.

Gorlin–Goltz syndrome, or basal cell nevus syndrome, is an autosomal dominant disorder caused by mutations involving the PTCH gene. Patients develop multiple basal cell carcinomas, sometimes beginning in childhood, along with jaw cysts, skeletal abnormalities, and characteristic pits of the palms and soles.

Bazex syndrome is an X-linked dominant disorder associated with early development of multiple facial basal cell carcinomas and characteristic atrophic skin changes.

Xeroderma pigmentosum is an autosomal recessive disorder involving defective DNA repair. Patients develop multiple BCCs, SCCs, and melanomas at unusually young ages because of extreme sensitivity to ultraviolet radiation.

Patients with albinism have decreased protective melanin and therefore have a substantially increased risk of ultraviolet-induced skin malignancies.

⸻

Diagnosis

Any persistent or suspicious eyelid lesion should undergo careful evaluation. Important historical features include duration, rate of growth, previous skin cancer, previous radiation exposure, arsenic exposure, chronic inflammatory disease, and significant UV exposure.

A lesion that repeatedly recurs after treatment as a benign condition deserves particular attention. For example, a “chalazion” that repeatedly returns in the same location should raise concern for sebaceous gland carcinoma.

Physical Examination

The eyelid lesion should be examined carefully for ulceration, abnormal pigmentation, irregular texture, persistent crusting, spontaneous bleeding, and loss of normal eyelid architecture.

Loss of eyelashes, or madarosis, is an especially important sign. Poliosis, or whitening of eyelashes, may also occur.

Abnormal vascularity should be documented. Feeder vessels and telangiectatic vessels at the tumor margins are concerning features.

Signs such as proptosis, diplopia, restricted ocular motility, or external ophthalmoplegia suggest possible orbital invasion and require urgent further evaluation.

Regional lymph nodes, particularly the preauricular, submandibular, and cervical nodes, should be examined for enlargement.

⸻

Biopsy and Histopathology

Histopathologic confirmation is essential for suspected malignant eyelid tumors.

In many lesions, an incisional biopsy can establish the diagnosis before definitive treatment. However, melanoma requires careful biopsy planning because depth of invasion is essential for staging and prognosis.

Basal cell carcinoma typically demonstrates nests of basaloid cells with peripheral palisading.

Squamous cell carcinoma demonstrates atypical squamous cells, often with keratinization and keratin pearls, invading through the basement membrane.

Sebaceous gland carcinoma shows large atypical cells containing foamy lipid-rich cytoplasm, prominent nuclei, and infiltrative growth in lobules, cords, and nests. Pagetoid epithelial spread may also be present.

Melanoma demonstrates atypical melanocytes with abnormal proliferation, loss of normal maturation, and potentially pagetoid upward migration through the epidermis.

⸻

Treatment

Treatment depends on the tumor type, size, location, depth, and extent of spread.

For basal cell carcinoma and squamous cell carcinoma, complete surgical removal with margin control is the standard approach. Techniques include Mohs micrographic surgery or excision with frozen- or permanent-section margin assessment. These approaches provide high cure rates while preserving as much normal eyelid tissue as possible.

For sebaceous gland carcinoma, treatment typically involves complete excision with careful margin control. Because of the possibility of pagetoid spread, conjunctival map biopsies may be required. Additional therapy may be considered when microscopic disease persists. Extensive orbital invasion may necessitate orbital exenteration.

Management of malignant melanoma depends heavily on tumor thickness and stage. Surgical excision with appropriate margins is required, while selected patients may need sentinel lymph node biopsy, lymphatic mapping, and systemic oncologic management.

Radiotherapy may be considered in selected patients when surgery is contraindicated or as an adjunct in particular tumor types.

⸻

Follow-up

Patients generally require close postoperative follow-up initially to ensure adequate wound healing and confirm that no early recurrence is present.

Long-term surveillance is essential. Stable lower-risk tumors may be followed approximately every 6–12 months, while aggressive tumors such as sebaceous carcinoma and melanoma require more frequent and prolonged monitoring.

Patients should also undergo regular full-body skin examinations through a dermatologist or primary care physician because the presence of one skin malignancy increases the likelihood of additional lesions.

Patients with sebaceous carcinoma or melanoma often require coordinated follow-up with medical oncology, while radiation oncology may be involved when radiotherapy is required.

⸻

Patient Education

Patients should be encouraged to minimize ultraviolet exposure by using sunscreen, hats, sunglasses, and other protective measures.

Any new or recurrent eyelid lesion showing growth, ulceration, bleeding, color change, loss of eyelashes, persistent crusting, or alteration of normal eyelid architecture should be evaluated promptly.

Patients previously treated for an eyelid malignancy should understand that long-term surveillance is necessary because recurrence or development of a second skin cancer can occur.

⸻

Prognosis and Complications

The prognosis depends heavily on the specific tumor type, stage at diagnosis, and adequacy of surgical excision.

Early basal cell carcinoma generally has an excellent prognosis when completely removed, whereas advanced SCC, sebaceous carcinoma, and melanoma carry greater risks of regional and systemic spread.

Potential complications include destruction of eyelid anatomy, impaired eyelid function, orbital invasion, intracranial extension, lymphatic or distant metastasis, visual loss, and death.

The most important principle is early recognition and biopsy of suspicious eyelid lesions, because timely diagnosis can prevent extensive local destruction and potentially life-threatening metastatic disease.

Ophthalmology – Benign Eyelid Neoplasms

Benign eyelid neoplasms are nonmalignant proliferations arising from the numerous tissues that make up the eyelid. The eyelid contains the epidermis, dermis, and deeper adnexal structures, so benign lesions can arise from epithelial cells, melanocytes, vascular tissue, or the various eyelid glands.

The epidermis consists predominantly of keratinocytes but also contains melanocytes, Merkel cells, and Langerhans cells. Beneath it, the dermis contains blood vessels, nerves, and lymphatics. The deeper adnexal tissues include sebaceous, eccrine, apocrine, holocrine, and meibomian glands. Abnormal benign proliferation or obstruction involving any of these structures can produce an eyelid lesion.

Most eyelid tumors are benign, accounting for approximately 54–84% of eyelid tumors. Common lesions encountered in ophthalmic practice include chalazia, epidermal inclusion cysts, squamous papillomas, seborrheic keratoses, melanocytic nevi, hidrocystomas, xanthelasma, and capillary hemangiomas.

Epidemiology

The frequency varies considerably according to lesion type. Chalazia and epidermal inclusion cysts are among the most frequently encountered benign eyelid lesions in general ophthalmology.

Among surgically removed benign eyelid lesions, approximately 26% are squamous papillomas and 21% are seborrheic keratoses. Seborrheic keratoses become extremely common with increasing age and may be found in the majority of adults older than 50 years.

Capillary hemangioma is one of the most common eyelid tumors of infancy, occurring in approximately 1–2.6% of live births.

Risk Factors

Risk factors depend on the particular lesion. Meibomian gland dysfunction and ocular rosacea predispose to recurrent chalazia and hordeola. Previous eyelid trauma or surgery can lead to epidermal inclusion cyst formation because epidermal tissue may become implanted within the dermis.

Capillary hemangiomas are more common in females, with an approximate 3:1 female-to-male ratio.

Human papillomavirus may be associated with some squamous papillomas. Chronic ultraviolet exposure, increasing age, and substantial lifetime sun exposure predispose to several epithelial lesions and, more importantly, increase the risk of premalignant and malignant eyelid disease.

Hypercholesterolemia and familial disorders of lipid metabolism are associated with xanthoma and xanthelasma.

Prevention therefore includes appropriate UV protection and sunscreen, good eyelid hygiene in patients prone to inflammatory glandular disease, and management of systemic lipid abnormalities when appropriate.

Common Benign Eyelid Lesions

Chalazion

A chalazion is a chronic sterile lipogranulomatous inflammatory lesion caused by retention of sebaceous secretions, usually from a meibomian gland but occasionally involving the glands of Zeis.

The retained lipid triggers a granulomatous inflammatory reaction. A chalazion typically presents as a relatively painless, localized eyelid nodule. When an eyelid gland becomes acutely infected, the clinical lesion is generally termed a hordeolum.

Ocular rosacea and chronic meibomian gland dysfunction predispose to recurrent lesions.

Initial treatment consists of warm compresses and gentle massage, usually several times daily, together with appropriate eyelid hygiene. Topical antibiotics may be useful when there is associated blepharitis or drainage, although an uncomplicated chalazion itself is sterile.

Persistent lesions may require incision and curettage or intralesional corticosteroid injection. Triamcinolone injection can cause local skin depigmentation and atrophy. In patients with significant ocular rosacea or recurrent meibomian gland disease, systemic tetracycline-class therapy may sometimes be considered.

A particularly important clinical point is that a recurrent or atypical unilateral chalazion should raise suspicion for an eyelid malignancy, especially sebaceous carcinoma, and biopsy should be considered.

Epidermal Inclusion Cyst

An epidermal inclusion cyst is a superficial, usually round lesion containing keratin. It develops when epidermal tissue becomes trapped within the deeper dermis, sometimes following trauma or eyelid surgery.

Histologically, the cyst is lined by stratified squamous epithelium and contains keratinaceous material.

Treatment is generally performed for symptoms, enlargement, diagnostic uncertainty, or cosmetic reasons. The lesion can be completely excised with its capsule intact to minimize recurrence. Selected cystic lesions may instead be marsupialized.

Capillary Hemangioma

A capillary hemangioma of infancy is a benign vascular proliferation. It typically appears as a pink, red, or violaceous lesion and undergoes a characteristic natural history consisting of rapid proliferation, stabilization, and subsequent spontaneous involution.

Many lesions can therefore be observed. Approximately half regress substantially by 5 years of age and about 70% by 7 years, with continued improvement possible thereafter.

Observation is appropriate only when the lesion does not threaten vision or other important functions. Periocular hemangiomas require careful monitoring because they may cause visual-axis obstruction, astigmatism, anisometropia, strabismus, and amblyopia.

Large or strategically located lesions can also distort facial structures. Multiple cutaneous hemangiomas may occasionally be associated with visceral vascular lesions.

Treatment is indicated when there is a threat to visual development, rapid progression, significant anatomical distortion, ulceration, or other functional complications. Systemic propranolol has become an important treatment for problematic infantile hemangiomas, with therapy requiring appropriate pediatric assessment and monitoring. Corticosteroids, intralesional therapy, laser treatment, and other approaches may be considered in selected circumstances.

Squamous Cell Papilloma

A squamous papilloma is a benign epithelial proliferation that commonly forms a pedunculated lesion with finger-like projections. Histologically, it contains a vascular connective-tissue core surrounded by acanthotic and hyperkeratotic squamous epithelium.

Clinically benign lesions do not necessarily require treatment. They may be removed when they become irritated, repeatedly traumatized, bleed, enlarge, interfere with vision, or are cosmetically undesirable.

Any lesion with atypical features should be biopsied rather than assumed to be a benign papilloma.

Seborrheic Keratosis

Seborrheic keratosis is an extremely common benign epithelial lesion, particularly among older adults. It usually appears as a well-demarcated, gray-to-brown, greasy or scaly papule or plaque, often giving the impression that it has been “stuck onto” the skin.

These lesions arise from keratinocytes and demonstrate several different histopathologic patterns.

Treatment is optional for clearly benign lesions. Removal may be performed for irritation, bleeding, growth, or cosmetic reasons using techniques such as excision, cryotherapy, or selected ablative procedures.

Because pigmented or irregular seborrheic keratoses can occasionally resemble malignant lesions, diagnostic uncertainty should prompt biopsy.

Melanocytic Nevus

A melanocytic nevus consists of collections of melanocytes derived from the neural crest. Eyelid nevi can be flat or elevated, smooth or verrucous, and may range from deeply pigmented to essentially nonpigmented.

Histologically, nevi may be classified as junctional, compound, or intradermal according to the location of the nevus cells.

Stable lesions with a classic benign appearance can generally be observed. Changes in size, pigmentation, border, surface characteristics, ulceration, or bleeding warrant reassessment and possible biopsy.

Patients with numerous atypical or dysplastic nevi may have an increased lifetime risk of melanoma and require appropriate dermatologic surveillance.

Apocrine Hidrocystoma

An apocrine hidrocystoma is a benign cystic lesion commonly arising from the glands of Moll. Similar cystic lesions can originate from other eyelid glands.

They usually appear as smooth, translucent or bluish cystic nodules. Treatment is generally unnecessary unless the lesion causes symptoms or cosmetic concern.

Management may involve excision or marsupialization. Large or multiple lesions may occasionally be treated using other destructive techniques.

Xanthelasma and Xanthoma

Xanthelasma consists of yellowish lipid-containing plaques, classically occurring along the nasal aspect of the upper eyelids, although other periocular locations can be involved.

Histologically, these lesions contain lipid-laden histiocytes within the dermis.

Although many affected patients have normal lipid levels, xanthelasma can be associated with hypercholesterolemia or familial lipid disorders, particularly when it develops at a relatively young age. Appropriate patients should therefore undergo systemic evaluation of their cardiovascular and lipid risk factors.

Treatment is primarily cosmetic and may include surgical excision or laser-based treatment. Recurrence can occur even after successful removal.

Clinical Assessment

History is particularly important when evaluating an eyelid lesion. The clinician should determine how long the lesion has been present and whether it is changing in size, shape, pigmentation, or symptoms.

Most noninflammatory benign tumors are either stable or grow slowly. In contrast, rapid growth, spontaneous bleeding, ulceration, necrosis, or prominent abnormal vessels should raise concern for malignancy.

Previous skin cancers, systemic malignancies, eyelid surgery, trauma, radiation exposure, chronic inflammatory eyelid disease, and significant UV exposure should be documented.

Persistent unilateral “blepharitis” deserves particular attention because some malignant eyelid tumors, especially sebaceous carcinoma, may masquerade as chronic inflammatory eyelid disease.

Examination

Both eyelids and the surrounding adnexa should be examined carefully. The eyelid should be everted when appropriate to inspect the tarsal conjunctiva, particularly when sebaceous carcinoma or another infiltrative lesion is a concern.

The lesion should be evaluated for size, location, color, pigmentation, surface architecture, mobility, ulceration, necrosis, discharge, bleeding, and abnormal vascularity.

The eyelashes and meibomian glands should also be examined. Madarosis, meaning loss of eyelashes, is an important warning sign. Poliosis, destruction of meibomian gland architecture, or distortion of the eyelid margin should also be documented.

Regional preauricular, submandibular, and cervical lymph nodes should be examined when malignancy is suspected.

A complete slit-lamp examination should accompany evaluation of significant eyelid lesions, with further ocular examination dictated by the clinical findings.

Warning Signs for Malignancy

Although many eyelid lesions are benign, several features should make the clinician reconsider the diagnosis. Particularly concerning findings include rapid or progressive enlargement, ulceration, spontaneous bleeding, necrosis, destruction of the eyelid margin, loss of eyelashes, abnormal feeder vessels, fixation to deeper tissue, recurrent lesions after apparently adequate treatment, and regional lymphadenopathy.

A lesion that behaves atypically should not simply be treated repeatedly as a benign cyst or chalazion.

Investigations and Biopsy

Routine laboratory testing and imaging are generally unnecessary for a typical benign eyelid lesion.

Discharge can be cultured when infection is suspected. Systemic investigations may be appropriate when there is concern for an associated systemic disorder, such as lipid testing in selected patients with xanthelasma.

Imaging is reserved for lesions in which there is concern for orbital extension, deep tissue involvement, systemic disease, or malignancy.

When the diagnosis is uncertain, histopathologic examination is the definitive method of diagnosis. Depending on lesion size and clinical suspicion, either an incisional or excisional biopsy may be performed.

Management Principles

A clearly benign, asymptomatic lesion can often simply be observed. Treatment becomes appropriate when the lesion interferes with vision or eyelid function, causes recurrent irritation or bleeding, enlarges, is cosmetically unacceptable to the patient, or has uncertain diagnostic features.

Simple benign lesions may be treated with excision, marsupialization, cryotherapy, or other lesion-specific techniques.

When a lesion is clinically suspicious for malignancy, management changes substantially. Biopsy and histopathologic diagnosis are essential, and definitive treatment should follow oncologic principles rather than routine cosmetic removal.

Follow-up

Treated lesions should be monitored for recurrence. Apparent “recurrence” after excision may represent incomplete removal, development of a new lesion, or an initially incorrect diagnosis, so recurrent or changing lesions deserve reassessment and sometimes repeat biopsy.

Infants with periocular capillary hemangiomas require especially careful follow-up during the proliferative phase because amblyopia can develop rapidly if the lesion obstructs the visual axis or induces significant refractive error.

Patient Education

Patients should be encouraged to practice sun protection, including appropriate sunscreen and protective eyewear, particularly when they have substantial UV exposure or multiple sun-related skin lesions.

Those with xanthelasma may benefit from evaluation and management of systemic lipid abnormalities.

Patients should return for reassessment when an eyelid lesion develops rapid growth, bleeding, ulceration, pain, loss of eyelashes, color change, or recurrent growth after treatment.

Prognosis

The prognosis for true benign eyelid neoplasms is excellent. Many lesions require no treatment, while symptomatic or cosmetically troublesome lesions can usually be successfully removed.

The most important clinical challenge is not treatment of the benign lesion itself, but ensuring that an apparently harmless eyelid lesion is not actually a premalignant or malignant process masquerading as a benign condition.

Ophthalmology – Eyelid Laceration

Eyelid lacerations are traumatic cuts or tears involving the eyelid and may result from sharp trauma, blunt trauma, or diffuse facial trauma. They can involve the non-marginal eyelid, eyelid margin, or canalicular drainage system, sometimes with associated avulsion of the medial canthal tendon. Because eyelid trauma can coexist with serious ocular and orbital injuries, the first priority is always to exclude globe rupture, intraocular injury, orbital foreign body, optic nerve injury, and facial fractures.

Approximately 25% of eyelid injuries involve the eyelid margin, while around 15% involve the canalicular system. Canalicular lacerations are particularly common in young adults, with an average age around 24 years, and occur predominantly in males. Protective eyewear is important for prevention during hazardous work and recreational activities. Appropriate protective glasses should meet recognized standards such as ANSI Z87.1.

Pathophysiology and Mechanism

Sharp objects can directly cut through the eyelid skin, margin, or lacrimal drainage structures. Reported causes include fingernails, scissors, pencils, glass, tree branches, fishing equipment, and door handles.

Blunt or diffuse trauma can tear the eyelid by traction rather than direct penetration. Sudden lateral displacement of the eyelid can disrupt the medial canthal tendon and canaliculi, which is particularly important in injuries such as dog bites.

Eyelid lacerations frequently coexist with deeper injury. About 44% of eyelid trauma may be associated with globe injury, and patients with canalicular injuries may also have globe rupture, facial fractures, optic neuropathy, retinal detachment, or head trauma.

Diagnosis

The patient should first be stabilized for any life-threatening trauma. Once stable, a detailed history should establish when and how the injury occurred, including the type, direction, and velocity of the traumatic object. The mechanism can suggest an occult orbital or intraocular foreign body.

Previous visual status and tetanus immunization status should also be documented.

A complete ophthalmic examination is essential. Visual acuity should be checked whenever possible, and the clinician should carefully assess for open globe injury before manipulating the eyelid.

The laceration should be evaluated for its length, depth, and location. Determine whether it is partial or full thickness and whether the eyelid margin is involved.

Visible orbital fat prolapsing through the wound is an important finding because it indicates violation of the orbital septum and raises concern for deeper orbital injury, including possible levator damage.

Any laceration located medial to the punctum should be considered suspicious for canalicular injury until proven otherwise.

Diagnostic Testing

If the injury is small externally but resulted from penetrating trauma, there may still be a deeply retained foreign body. When the history or examination raises concern for an occult orbital foreign body, thin-cut CT of the orbits without contrast, with axial and coronal imaging, is generally appropriate.

When canalicular damage is suspected, an ophthalmologist may perform probing and irrigation of the lacrimal drainage system to determine whether the canaliculus has been disrupted.

Treatment

Tetanus immunization should be updated as appropriate.

Antibiotic use depends on the nature of the injury. Routine oral antibiotics for uncomplicated clean eyelid lacerations are not always necessary, but they may be considered based on contamination and mechanism. Animal and human bite injuries warrant prophylactic systemic antibiotics because of the increased risk of infection.

If the globe is intact, the wound can be kept moist with an appropriate dressing while awaiting definitive repair.

An apparently large tissue defect does not always mean that eyelid tissue has been lost. The skin and orbicularis muscle often retract after injury, creating the appearance of missing tissue. True tissue loss is less common but requires more complex reconstruction, often by an oculoplastic surgeon.

Surgical Repair

Repair may be performed in a procedure room or operating room depending on the extent of injury, patient cooperation, associated trauma, and need for sedation or general anesthesia.

Any globe injury should be repaired before the eyelid laceration.

Repair is generally performed within approximately 24–48 hours, although the exact timing depends on contamination, associated injuries, and tissue condition.

Simple non-marginal lacerations may be closed in layers. Deeper tissues can be approximated with absorbable sutures, followed by careful skin closure.

Eyelid-margin lacerations require precise anatomic repair to restore the normal contour and avoid postoperative notching, trichiasis, or poor eyelid-globe apposition. These injuries should be managed by an ophthalmic surgeon experienced in eyelid repair.

Canalicular lacerations require specialized repair, frequently using silicone intubation. Options include monocanalicular stents, such as a Mini-Monoka, or bicanalicular systems such as Crawford tubes, depending on the pattern of injury.

Follow-up

After repair, a thin layer of topical antibiotic ointment is generally applied to the wound several times daily.

Follow-up is commonly arranged within 3–7 days, depending on the severity and complexity of the injury. Patients with associated ocular trauma require follow-up appropriate to those injuries as well.

Hospital admission is usually unnecessary for an isolated eyelid laceration, but patients with a ruptured globe or significant associated trauma may require inpatient management.

Patient Education

Patients should be instructed to watch for signs of wound infection, particularly increasing redness, swelling, tenderness, pain, or discharge.

They should also be advised to return promptly for worsening vision, increasing ocular pain, new diplopia, or excessive tearing, because these symptoms may indicate associated ocular injury or lacrimal drainage complications.

Prognosis

The prognosis is usually very good when the injury is properly evaluated and anatomically repaired. Most patients achieve satisfactory functional and cosmetic outcomes.

Complications

Possible complications include infection, persistent tearing from canalicular obstruction, trichiasis, lagophthalmos with corneal exposure, eyelid-margin notching, and displacement of a silicone lacrimal stent.

Some patients require secondary procedures to correct persistent eyelid deformity, lacrimal dysfunction, or cosmetic abnormalities.

Ophthalmology – Exposure Keratopathy

Exposure keratopathy is corneal damage caused by excessive evaporation of the tear film and abnormal tear distribution when the eyelids do not close or blink properly. Inadequate eyelid protection leaves part of the cornea exposed, resulting initially in epithelial breakdown and, in severe cases, corneal ulceration, infection, thinning, scarring, or perforation.

Exposure keratopathy is relatively uncommon overall, although its prevalence increases with age and in hospitalized or neurologically impaired patients. Prevention depends on identifying patients at risk and protecting the ocular surface before significant corneal damage develops. This is particularly important in patients undergoing general anesthesia or intensive care, where incomplete eyelid closure and reduced blinking can rapidly cause exposure-related injury.

Pathophysiology

Normal blinking continuously redistributes the tear film across the cornea. The tear film contains aqueous, lipid, and mucin components, all of which contribute to maintaining a smooth, hydrated, and protected ocular surface.

When eyelid movement is reduced or the lids cannot close completely, several abnormalities develop. Tears evaporate excessively from the exposed portion of the cornea, fresh tears are not adequately spread across the ocular surface, and normal mixing of tear-film components is impaired. Tear drainage and recycling through the nasolacrimal system may also become abnormal.

The result is progressive desiccation of the corneal epithelium, followed by punctate epithelial erosions and potentially more severe epithelial breakdown.

Etiology

Exposure keratopathy has several important causes. Neurogenic causes include facial nerve palsy, particularly Bell palsy, where weakness of the orbicularis oculi prevents complete eyelid closure.

Anatomic causes include cicatricial eyelid disease, previous blepharoplasty, Stevens–Johnson syndrome, other mucocutaneous scarring disorders, eyelid malposition, and proptosis from conditions such as thyroid eye disease or orbital tumors.

Degenerative neurologic disorders such as Parkinson disease, Alzheimer disease, and advanced dementia may decrease spontaneous blink frequency and contribute to exposure.

Patients with an altered level of consciousness, including sedated, critically ill, or anesthetized patients, are also at increased risk because spontaneous blinking and voluntary eyelid closure are reduced or absent.

Common associated conditions include Bell palsy, lower eyelid ectropion, Parkinson disease, and neurotrophic corneal disease.

Diagnosis

The history often reveals an underlying condition associated with impaired eyelid closure or blinking. Patients may report that their eyes remain partially open during sleep, known as nocturnal lagophthalmos.

Symptoms typically develop subacutely or chronically and may include foreign-body sensation, photophobia, excessive tearing, irritation, and decreased visual acuity.

An important exception occurs in patients with associated neurotrophic keratopathy. Because corneal sensation is reduced, these patients may have advanced epithelial damage with surprisingly little pain or discomfort.

Physical Examination

External examination should assess spontaneous blinking and eyelid closure. Findings may include lagophthalmos, reduced blink frequency, a widened palpebral fissure, ectropion, eyelid retraction, or other eyelid abnormalities. Patients with facial nerve palsy may also demonstrate brow ptosis and weakness of facial movement.

The patient should first be observed blinking spontaneously. They should then be asked to gently close the eyes and subsequently close them forcefully. Any residual opening between the eyelids should be measured.

Corneal sensation should be tested before topical anesthetic is applied, particularly when neurotrophic disease is suspected.

Slit-lamp examination frequently demonstrates punctate epithelial erosions, typically most pronounced in the inferior cornea, corresponding to the exposed portion of the ocular surface. In more severe exposure or markedly reduced blinking, epithelial abnormalities may become diffuse.

Other findings may include decreased tear breakup time and reduced tear production, particularly in patients with facial nerve dysfunction. Severe or prolonged disease may progress to persistent epithelial defects, corneal ulceration, microbial infection, stromal thinning, scarring, or perforation.

Fluorescein staining helps demonstrate the extent of epithelial damage and can be used to evaluate tear-film breakup. A Schirmer test may be helpful when associated aqueous tear deficiency is suspected.

Assessment of Bell phenomenon can be performed, but its clinical value is limited because the position of the eye during voluntary examination does not always accurately predict globe position during sleep.

Differential Diagnosis

Important differential diagnoses include dry eye syndrome, Sjögren syndrome, neurotrophic keratopathy, medication-related ocular surface toxicity, and blepharitis.

Exposure keratopathy and neurotrophic keratopathy can coexist. This combination is particularly dangerous because the eye experiences both mechanical exposure and impaired epithelial healing, while reduced corneal sensation may delay recognition of severe disease.

Treatment

The first objective is to maintain continuous lubrication and protection of the exposed cornea.

Artificial tears may be used frequently during the day. More viscous gels provide longer-lasting lubrication, while ophthalmic ointments provide the longest protection and are particularly useful at bedtime.

Treatment intensity should correspond to the severity of exposure. Mild nocturnal lagophthalmos may require only nighttime ointment, whereas marked facial nerve palsy with a wide palpebral opening may require very frequent lubrication throughout the day.

Eyelid taping during sleep can help maintain closure. In hospitalized, sedated, or unconscious patients, the eyelids may be taped closed or covered with an appropriate transparent moisture-retaining dressing to prevent corneal drying.

Additional Therapy

Moisture chambers or moisture goggles reduce evaporation and can be very effective, especially during sleep.

Punctal occlusion can help retain tears in selected patients.

Soft bandage contact lenses have a limited role because reduced blinking and impaired ocular surface defense may increase the risk of infection. When used, they require careful ophthalmologic monitoring.

Scleral lenses can be particularly useful in selected chronic cases because they create a reservoir of fluid over the cornea, protecting the epithelium while providing a stable optical surface.

Patients who have both exposure and neurotrophic corneal disease should generally be managed with a corneal specialist because of their substantial risk of sight-threatening complications.

Surgical Treatment

Surgery should be considered when lubrication and conservative measures are inadequate or when the underlying eyelid abnormality is unlikely to resolve.

Patients with ectropion or horizontal eyelid laxity may require eyelid tightening procedures, such as a lateral tarsal strip.

In facial nerve palsy, placement of a weight in the upper eyelid can improve passive eyelid closure by gravity. Lower eyelid elevation or tightening may also be necessary.

Patients with upper eyelid retraction may benefit from recession of the eyelid retractors. If proptosis is responsible, treatment may include orbital decompression or removal of an orbital lesion, depending on the cause.

A partial or complete tarsorrhaphy may be required in severe or persistent cases. This procedure partially closes the eyelids to reduce the amount of exposed cornea.

Botulinum toxin can occasionally be injected into the upper eyelid elevator muscles to create a temporary protective ptosis, although its onset is delayed and the amount of corneal coverage can be variable.

Follow-up

Patients with acute or worsening exposure keratopathy require close ophthalmologic follow-up, particularly when an epithelial defect is present.

Monitoring should focus on the extent of epithelial breakdown, corneal thinning, signs of infection, visual acuity, eyelid closure, and progression or recovery of the underlying disease.

Patient Education

Patients should understand the importance of regular lubrication and complete eyelid protection, particularly during sleep.

They should seek urgent ophthalmologic assessment if they develop sudden worsening of vision, increasing pain, photophobia, redness, or discharge, because these findings may indicate corneal ulceration or infection.

Prognosis

The prognosis depends on the severity, duration, and underlying cause. Mild exposure treated promptly generally resolves without permanent damage.

Longstanding or severe exposure, particularly when accompanied by neurotrophic disease, carries a substantially greater risk of permanent visual impairment.

Complications

The major complications are persistent corneal epithelial defects, corneal ulceration, microbial keratitis, stromal thinning, corneal scarring, and corneal perforation. Severe untreated exposure keratopathy can therefore become a sight-threatening condition.